BLCO 📈 Bausch + Lomb - Overview

Bausch + Lomb Corporation is a leading eye health company with a global presence, operating in numerous countries including the United States, China, France, Japan, and the United Kingdom, among others. The company's business is divided into three main segments: Vision Care, Pharmaceuticals, and Surgical, each catering to different aspects of eye health. The Vision Care segment, for instance, offers a wide range of contact lenses, including daily disposable and frequently replaced lenses, as well as contact lens care products such as over-the-counter eye drops, eye vitamins, and mineral supplements. These products are designed to address various eye conditions, including eye allergies, conjunctivitis, dry eye, and redness relief, providing users with a comprehensive solution for their eye care needs.

The Pharmaceuticals segment of Bausch + Lomb Corporation focuses on developing and marketing proprietary and generic pharmaceutical products. These products are used for post-operative treatments, as well as for the treatment of specific eye conditions such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. By offering a range of pharmaceutical products, the company is able to provide eye care professionals with the necessary tools to treat a variety of eye conditions, ultimately improving patient outcomes. Furthermore, the company's pharmaceutical products are designed to be used in conjunction with its other eye care products, providing a holistic approach to eye health.

The Surgical segment of the company provides medical device equipment, consumables, and technologies for the treatment of various eye conditions, including cataracts, corneal, vitreous, and retinal eye conditions. The company's product portfolio in this segment includes intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices used in cataract surgery. By offering a comprehensive range of surgical products, Bausch + Lomb Corporation is able to support eye care professionals in providing high-quality surgical care to their patients. The company's products are sold through a combination of direct sales forces and independent distributors, allowing it to reach a wide range of customers globally.

Bausch + Lomb Corporation has a long history, dating back to 1853, and is headquartered in Vaughan, Canada. The company operates as a subsidiary of Bausch Health Companies Inc. and is listed on the New York Stock Exchange (NYSE) under the ticker symbol BLCO. With a strong focus on innovation and customer satisfaction, Bausch + Lomb Corporation is committed to improving eye health outcomes for patients around the world. The company's website, https://www.bausch.com, provides more information on its products, services, and mission. The company's ISIN is CA0717051076, and its common stock is classified under the GICS Sub Industry of Health Care Supplies.